25 XP   0   0   10

BG Medicine Inc
Buy, Hold or Sell?

Let's analyse BG Medicine Inc together

PenkeI guess you are interested in BG Medicine Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BG Medicine Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BG Medicine Inc

I send you an email if I find something interesting about BG Medicine Inc.

Quick analysis of BG Medicine Inc (30 sec.)










What can you expect buying and holding a share of BG Medicine Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.88
When do you have the money?
1 year
How often do you get paid?
11.1%

What is your share worth?

Current worth
$-0.17
Expected worth in 1 year
$-1.06
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-11,605.0%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%

1. Valuation of BG Medicine Inc (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$-6.76 - $16.51

Total Value Per Share

$-6.93 - $16.34

2. Growth of BG Medicine Inc (5 min.)




Is BG Medicine Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.9m$557k-$2.5m-128.2%

How much money is BG Medicine Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5.3m-$8m$2.7m52.1%
Net Profit Margin-338.6%-289.3%--

How much money comes from the company's main activities?

3. Financial Health of BG Medicine Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

What can you expect buying and holding a share of BG Medicine Inc? (5 min.)

Welcome investor! BG Medicine Inc's management wants to use your money to grow the business. In return you get a share of BG Medicine Inc.

What can you expect buying and holding a share of BG Medicine Inc?

First you should know what it really means to hold a share of BG Medicine Inc. And how you can make/lose money.

Speculation

The Price per Share of BG Medicine Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BG Medicine Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BG Medicine Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.17. Based on the TTM, the Book Value Change Per Share is $-0.22 per quarter. Based on the YOY, the Book Value Change Per Share is $0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.22 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BG Medicine Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.61-611,724.6%-0.61-611,724.6%-0.71-708,960.5%-1.27-1,271,979.2%-1.23-1,225,510.3%
Usd Book Value Change Per Share-0.22-222,693.1%-0.22-222,693.1%0.14142,952.6%1.331,326,364.5%0.26257,674.2%
Usd Dividend Per Share0.22219,791.8%0.22219,791.8%0.000.0%0.0443,958.4%0.0224,421.3%
Usd Total Gains Per Share0.00-2,901.3%0.00-2,901.3%0.14142,952.6%1.371,370,322.8%0.28282,095.5%
Usd Price Per Share0.37-0.37-0.46-1.78-0.99-
Price to Earnings Ratio-0.60--0.60--0.65--1.23--0.68-
Price-to-Total Gains Ratio-125.81--125.81-3.22--26.38--26.38-
Price to Book Ratio-2.10--2.10-9.41-16.77-9.32-
Price-to-Total Gains Ratio-125.81--125.81-3.22--26.38--26.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.220.04
Usd Book Value Change Per Share-0.221.33
Usd Total Gains Per Share0.001.37
Gains per Quarter (10000000 shares)-29,012.5213,703,228.30
Gains per Year (10000000 shares)-116,050.0854,812,913.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18791673-8907723-11606017583355305457954812903
217583345-17815445-2321103516669106109157109625816
326375018-26723168-3481605275004159163736164438729
435166690-35630890-4642107033338212218315219251642
543958363-44538613-5802608791673265272894274064555
652750035-53446336-69631010550007318327472328877468
761541708-62354058-81236012308342371382051383690381
870333380-71261781-92841014066676424436630438503294
979125053-80169503-104446015825011477491208493316207
1087916725-89077226-116051017583345530545787548129120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.011.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.07.00.022.2%2.09.00.018.2%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%1.00.04.020.0%1.00.08.011.1%1.00.010.09.1%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.07.00.022.2%2.09.00.018.2%

Fundamentals of BG Medicine Inc

About BG Medicine Inc

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

Fundamental data was last updated by Penke on 2024-05-14 14:42:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BG Medicine Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit BG Medicine Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare BG Medicine Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -338.6% means that $-3.39 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BG Medicine Inc:

  • The MRQ is -338.6%. The company is making a huge loss. -2
  • The TTM is -338.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-338.6%TTM-338.6%0.0%
TTM-338.6%YOY-289.3%-49.3%
TTM-338.6%5Y-587.5%+248.9%
5Y-587.5%10Y-600.5%+13.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-338.6%5.3%-343.9%
TTM-338.6%5.9%-344.5%
YOY-289.3%5.1%-294.4%
5Y-587.5%7.0%-594.5%
10Y-600.5%6.7%-607.2%
1.1.2. Return on Assets

Shows how efficient BG Medicine Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BG Medicine Inc to the Medical Instruments & Supplies industry mean.
  • -248.6% Return on Assets means that BG Medicine Inc generated $-2.49 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BG Medicine Inc:

  • The MRQ is -248.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -248.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-248.6%TTM-248.6%0.0%
TTM-248.6%YOY-154.2%-94.4%
TTM-248.6%5Y-159.1%-89.5%
5Y-159.1%10Y-143.0%-16.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-248.6%0.7%-249.3%
TTM-248.6%0.9%-249.5%
YOY-154.2%1.4%-155.6%
5Y-159.1%1.5%-160.6%
10Y-143.0%1.5%-144.5%
1.1.3. Return on Equity

Shows how efficient BG Medicine Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BG Medicine Inc to the Medical Instruments & Supplies industry mean.
  • 0.0% Return on Equity means BG Medicine Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BG Medicine Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,447.8%+1,447.8%
TTM-5Y-1,844.8%+1,844.8%
5Y-1,844.8%10Y-1,024.9%-819.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%-1.5%
TTM-1.8%-1.8%
YOY-1,447.8%2.7%-1,450.5%
5Y-1,844.8%3.0%-1,847.8%
10Y-1,024.9%2.8%-1,027.7%

1.2. Operating Efficiency of BG Medicine Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient BG Medicine Inc is operating .

  • Measures how much profit BG Medicine Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BG Medicine Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -295.7% means the company generated $-2.96  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BG Medicine Inc:

  • The MRQ is -295.7%. The company is operating very inefficient. -2
  • The TTM is -295.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-295.7%TTM-295.7%0.0%
TTM-295.7%YOY-268.8%-26.9%
TTM-295.7%5Y-512.3%+216.6%
5Y-512.3%10Y-522.5%+10.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-295.7%7.4%-303.1%
TTM-295.7%4.6%-300.3%
YOY-268.8%9.3%-278.1%
5Y-512.3%9.5%-521.8%
10Y-522.5%9.0%-531.5%
1.2.2. Operating Ratio

Measures how efficient BG Medicine Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 3.96 means that the operating costs are $3.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BG Medicine Inc:

  • The MRQ is 3.957. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.957. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.957TTM3.9570.000
TTM3.957YOY3.642+0.315
TTM3.9575Y6.042-2.085
5Y6.04210Y6.149-0.108
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9571.111+2.846
TTM3.9571.124+2.833
YOY3.6421.149+2.493
5Y6.0421.110+4.932
10Y6.1491.051+5.098

1.3. Liquidity of BG Medicine Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if BG Medicine Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.65 means the company has $1.65 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BG Medicine Inc:

  • The MRQ is 1.653. The company is able to pay all its short-term debts. +1
  • The TTM is 1.653. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.653TTM1.6530.000
TTM1.653YOY1.059+0.594
TTM1.6535Y2.107-0.453
5Y2.10710Y1.807+0.299
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6532.311-0.658
TTM1.6532.401-0.748
YOY1.0592.556-1.497
5Y2.1072.672-0.565
10Y1.8072.619-0.812
1.3.2. Quick Ratio

Measures if BG Medicine Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BG Medicine Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.45 means the company can pay off $1.45 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BG Medicine Inc:

  • The MRQ is 1.446. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.446. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.446TTM1.4460.000
TTM1.446YOY0.938+0.507
TTM1.4465Y1.967-0.521
5Y1.96710Y1.807+0.160
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4461.064+0.382
TTM1.4461.064+0.382
YOY0.9381.231-0.293
5Y1.9671.369+0.598
10Y1.8071.553+0.254

1.4. Solvency of BG Medicine Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of BG Medicine Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BG Medicine Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 1.93 means that BG Medicine Inc assets are financed with 192.6% credit (debt) and the remaining percentage (100% - 192.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BG Medicine Inc:

  • The MRQ is 1.926. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.926. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.926TTM1.9260.000
TTM1.926YOY0.893+1.033
TTM1.9265Y1.023+0.904
5Y1.02310Y3.539-2.516
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9260.348+1.578
TTM1.9260.356+1.570
YOY0.8930.343+0.550
5Y1.0230.361+0.662
10Y3.5390.365+3.174
1.4.2. Debt to Equity Ratio

Measures if BG Medicine Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BG Medicine Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BG Medicine Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY8.388-8.388
TTM-5Y11.392-11.392
5Y11.39210Y6.329+5.063
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.521-0.521
TTM-0.546-0.546
YOY8.3880.500+7.888
5Y11.3920.611+10.781
10Y6.3290.642+5.687

2. Market Valuation of BG Medicine Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings BG Medicine Inc generates.

  • Above 15 is considered overpriced but always compare BG Medicine Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -0.60 means the investor is paying $-0.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BG Medicine Inc:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.597. Based on the earnings, the company is expensive. -2
  • The TTM is -0.597. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.597+0.597
MRQ-0.597TTM-0.5970.000
TTM-0.597YOY-0.650+0.054
TTM-0.5975Y-1.226+0.630
5Y-1.22610Y-0.681-0.545
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.00017.121-17.121
MRQ-0.59716.169-16.766
TTM-0.59716.130-16.727
YOY-0.65021.198-21.848
5Y-1.22620.998-22.224
10Y-0.68127.674-28.355
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BG Medicine Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.132. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.132. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-1.132+1.132
MRQ-1.132TTM-1.1320.000
TTM-1.132YOY-0.642-0.490
TTM-1.1325Y-1.467+0.334
5Y-1.46710Y-0.815-0.652
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-1.121+1.121
MRQ-1.132-1.779+0.647
TTM-1.1322.017-3.149
YOY-0.6424.353-4.995
5Y-1.4677.535-9.002
10Y-0.8150.417-1.232
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of BG Medicine Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of -2.10 means the investor is paying $-2.10 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BG Medicine Inc:

  • The EOD is -0.001. Based on the equity, the company is expensive. -2
  • The MRQ is -2.101. Based on the equity, the company is expensive. -2
  • The TTM is -2.101. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-2.101+2.100
MRQ-2.101TTM-2.1010.000
TTM-2.101YOY9.414-11.515
TTM-2.1015Y16.770-18.871
5Y16.77010Y9.317+7.453
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0012.758-2.759
MRQ-2.1012.732-4.833
TTM-2.1012.691-4.792
YOY9.4142.970+6.444
5Y16.7704.092+12.678
10Y9.3174.408+4.909
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BG Medicine Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.223-0.2230%0.143-256%1.326-117%0.258-186%
Book Value Per Share---0.174-0.1740%0.049-455%0.329-153%-1.995+1048%
Current Ratio--1.6531.6530%1.059+56%2.107-22%1.807-9%
Debt To Asset Ratio--1.9261.9260%0.893+116%1.023+88%3.539-46%
Debt To Equity Ratio----0%8.388-100%11.392-100%6.329-100%
Dividend Per Share--0.2200.2200%-+100%0.044+400%0.024+800%
Eps---0.612-0.6120%-0.709+16%-1.272+108%-1.226+100%
Free Cash Flow Per Share---0.322-0.3220%-0.718+123%-1.121+248%-1.064+230%
Free Cash Flow To Equity Per Share---0.230-0.2300%-0.319+39%-0.018-92%-0.030-87%
Gross Profit Margin--1.0571.0570%1.284-18%1.226-14%1.126-6%
Intrinsic Value_10Y_max--16.512--------
Intrinsic Value_10Y_min---6.758--------
Intrinsic Value_1Y_max---0.270--------
Intrinsic Value_1Y_min---1.019--------
Intrinsic Value_3Y_max--0.655--------
Intrinsic Value_3Y_min---2.784--------
Intrinsic Value_5Y_max--3.349--------
Intrinsic Value_5Y_min---4.231--------
Market Cap1137.440-364900%4151656.0004151656.0000%5243598.400-21%20237332.480-79%11242962.489-63%
Net Profit Margin---3.386-3.3860%-2.893-15%-5.875+73%-6.005+77%
Operating Margin---2.957-2.9570%-2.688-9%-5.123+73%-5.225+77%
Operating Ratio--3.9573.9570%3.642+9%6.042-35%6.149-36%
Pb Ratio-0.001+100%-2.101-2.1010%9.414-122%16.770-113%9.317-123%
Pe Ratio0.000+100%-0.597-0.5970%-0.650+9%-1.226+106%-0.681+14%
Price Per Share0.000-364900%0.3650.3650%0.461-21%1.779-79%0.988-63%
Price To Free Cash Flow Ratio0.000+100%-1.132-1.1320%-0.642-43%-1.467+30%-0.815-28%
Price To Total Gains Ratio-0.034+100%-125.808-125.8080%3.225-4001%-26.380-79%-26.380-79%
Quick Ratio--1.4461.4460%0.938+54%1.967-26%1.807-20%
Return On Assets---2.486-2.4860%-1.542-38%-1.591-36%-1.430-42%
Return On Equity----0%-14.4780%-18.4480%-10.2490%
Total Gains Per Share---0.003-0.0030%0.143-102%1.370-100%0.282-101%
Usd Book Value---1976000.000-1976000.0000%557000.000-455%3742600.000-153%-22693888.889+1048%
Usd Book Value Change Per Share---0.223-0.2230%0.143-256%1.326-117%0.258-186%
Usd Book Value Per Share---0.174-0.1740%0.049-455%0.329-153%-1.995+1048%
Usd Dividend Per Share--0.2200.2200%-+100%0.044+400%0.024+800%
Usd Eps---0.612-0.6120%-0.709+16%-1.272+108%-1.226+100%
Usd Free Cash Flow---3667000.000-3667000.0000%-8167000.000+123%-12746200.000+248%-12103000.000+230%
Usd Free Cash Flow Per Share---0.322-0.3220%-0.718+123%-1.121+248%-1.064+230%
Usd Free Cash Flow To Equity Per Share---0.230-0.2300%-0.319+39%-0.018-92%-0.030-87%
Usd Market Cap1137.440-364900%4151656.0004151656.0000%5243598.400-21%20237332.480-79%11242962.489-63%
Usd Price Per Share0.000-364900%0.3650.3650%0.461-21%1.779-79%0.988-63%
Usd Profit---5303000.000-5303000.0000%-8064000.000+52%-14113400.000+166%-13742444.444+159%
Usd Revenue--1566000.0001566000.0000%2787000.000-44%2575000.000-39%4756666.667-67%
Usd Total Gains Per Share---0.003-0.0030%0.143-102%1.370-100%0.282-101%
 EOD+2 -6MRQTTM+0 -0YOY+16 -195Y+14 -2110Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of BG Medicine Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-1-0.001
Net Profit Margin (MRQ)Greater than0-3.386
Operating Margin (MRQ)Greater than0-2.957
Quick Ratio (MRQ)Greater than11.446
Current Ratio (MRQ)Greater than11.653
Debt to Asset Ratio (MRQ)Less than11.926
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.486
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of BG Medicine Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2015-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,133
Total Liabilities4,109
Total Stockholder Equity-1,976
 As reported
Total Liabilities 4,109
Total Stockholder Equity+ -1,976
Total Assets = 2,133

Assets

Total Assets2,133
Total Current Assets1,951
Long-term Assets182
Total Current Assets
Cash And Cash Equivalents 1,525
Net Receivables 181
Inventory 145
Other Current Assets 100
Total Current Assets  (as reported)1,951
Total Current Assets  (calculated)1,951
+/-0
Long-term Assets
Property Plant Equipment 11
Intangible Assets 77
Other Assets 94
Long-term Assets  (as reported)182
Long-term Assets  (calculated)182
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,180
Long-term Liabilities2,929
Total Stockholder Equity-1,976
Total Current Liabilities
Short-term Debt 345
Accounts payable 558
Other Current Liabilities 372
Total Current Liabilities  (as reported)1,180
Total Current Liabilities  (calculated)1,275
+/- 95
Long-term Liabilities
Other Liabilities 335
Deferred Long Term Liability 229
Long-term Liabilities  (as reported)2,929
Long-term Liabilities  (calculated)564
+/- 2,365
Total Stockholder Equity
Common Stock11
Retained Earnings -166,305
Other Stockholders Equity 164,318
Total Stockholder Equity (as reported)-1,976
Total Stockholder Equity (calculated)-1,976
+/-0
Other
Cash and Short Term Investments 1,525
Current Deferred Revenue250
Liabilities and Stockholders Equity 2,133
Net Debt -1,525
Net Tangible Assets -2,053
Net Working Capital 771
Preferred Stock Total Equity 2,594



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312006-12-312005-12-312004-12-31
> Total Assets 
6,679
3,103
6,169
35,217
12,625
7,027
26,110
15,241
9,353
5,229
2,133
2,1335,2299,35315,24126,1107,02712,62535,2176,1693,1036,679
   > Total Current Assets 
4,855
1,645
4,825
33,496
10,915
3,616
25,316
14,576
8,835
4,851
1,951
1,9514,8518,83514,57625,3163,61610,91533,4964,8251,6454,855
       Cash And Cash Equivalents 
3,741
1,148
1,010
20,052
8,343
2,425
23,874
12,786
7,751
4,123
1,525
1,5254,1237,75112,78623,8742,4258,34320,0521,0101,1483,741
       Short-term Investments 
498
0
0
10,275
2,050
0
565
390
0
0
0
00039056502,05010,27500498
       Net Receivables 
323
222
2,060
0
278
786
115
395
319
174
181
18117431939511578627802,060222323
       Other Current Assets 
0
0
0
259
244
405
1,115
948
306
154
100
1001543069481,115405244259000
   > Long-term Assets 
1,824
1,458
1,344
1,721
1,710
3,411
794
665
518
378
182
1823785186657943,4111,7101,7211,3441,4581,824
       Property Plant Equipment 
1,686
1,287
1,274
1,164
983
604
301
197
192
117
11
111171921973016049831,1641,2741,2871,686
       Long Term Investments 
0
0
0
0
0
0
37
96
134
126
0
01261349637000000
       Intangible Assets 
0
0
0
500
625
541
456
372
192
135
77
77135192372456541625500000
       Long-term Assets Other 
138
171
70
57
102
2,266
37
96
134
126
94
9412613496372,2661025770171138
> Total Liabilities 
29,395
31,457
38,653
84,381
76,526
84,436
5,218
14,932
10,422
4,672
4,109
4,1094,67210,42214,9325,21884,43676,52684,38138,65331,45729,395
   > Total Current Liabilities 
8,329
8,364
8,755
12,614
4,900
12,095
5,203
8,315
7,350
4,579
1,180
1,1804,5797,3508,3155,20312,0954,90012,6148,7558,3648,329
       Short-term Debt 
5,727
3,584
1,233
1,225
1,156
96
0
3,245
4,353
2,960
345
3452,9604,3533,2450961,1561,2251,2333,5845,727
       Short Long Term Debt 
0
0
0
0
0
0
0
3,245
4,353
2,960
0
02,9604,3533,2450000000
       Accounts payable 
154
420
412
2,140
1,027
1,380
487
1,110
965
695
558
5586959651,1104871,3801,0272,140412420154
       Other Current Liabilities 
1,832
1,260
960
3,960
4,064
9,098
3,348
7,098
2,032
924
372
3729242,0327,0983,3489,0984,0643,9609601,2601,832
   > Long-term Liabilities 
21,066
23,093
29,898
71,767
71,626
72,341
15
6,617
3,072
93
2,929
2,929933,0726,6171572,34171,62671,76729,89823,09321,066
       Long term Debt Total 
0
0
0
0
0
0
0
6,612
2,961
0
0
002,9616,6120000000
       Other Liabilities 
0
0
0
445
471
248
15
5
111
93
335
33593111515248471445000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
229
2290000000000
> Total Stockholder Equity
-22,716
-28,354
-32,484
-49,164
-63,901
-77,409
20,892
309
-1,069
557
-1,976
-1,976557-1,06930920,892-77,409-63,901-49,164-32,484-28,354-22,716
   Common Stock
10
10
10
3
3
3
20
21
28
34
11
1134282120333101010
   Retained Earnings -166,305-161,002-152,938-137,089-113,320-95,738-78,576-62,439-35,971-31,229-30,212
   Capital Surplus 
0
0
0
0
0
0
134,192
137,377
151,841
161,525
0
0161,525151,841137,377134,192000000
   Treasury Stock00000000000
   Other Stockholders Equity 
714
1,157
1,769
23,084
25,932
16,618
134,192
137,377
151,841
161,525
164,318
164,318161,525151,841137,377134,19216,61825,93223,0841,7691,157714



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2015-12-31)

Gross Profit (+$)
totalRevenue1,566
Cost of Revenue-505
Gross Profit1,0611,061
 
Operating Income (+$)
Gross Profit1,061
Operating Expense-5,691
Operating Income-4,630-4,630
 
Operating Expense (+$)
Research Development1,774
Selling General Administrative3,615
Selling And Marketing Expenses302
Operating Expense5,6915,691
 
Net Interest Income (+$)
Interest Income0
Interest Expense-159
Other Finance Cost-159
Net Interest Income0
 
Pretax Income (+$)
Operating Income-4,630
Net Interest Income0
Other Non-Operating Income Expenses-514
Income Before Tax (EBT)-5,303-4,116
EBIT - interestExpense = -4,789
-5,144
-5,144
Interest Expense159
Earnings Before Interest and Taxes (EBIT)-4,630-5,144
Earnings Before Interest and Taxes (EBITDA)-4,543
 
After tax Income (+$)
Income Before Tax-5,303
Tax Provision-0
Net Income From Continuing Ops-5,303-5,303
Net Income-5,303
Net Income Applicable To Common Shares-6,958
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,196
Total Other Income/Expenses Net-514514
 

Technical Analysis of BG Medicine Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BG Medicine Inc. The general trend of BG Medicine Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BG Medicine Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BG Medicine Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
BG Medicine Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BG Medicine Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BG Medicine Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BG Medicine Inc.

BG Medicine Inc Daily Moving Average Convergence/Divergence (MACD) ChartBG Medicine Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BG Medicine Inc. The current adx is .

BG Medicine Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BG Medicine Inc.

BG Medicine Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BG Medicine Inc.

BG Medicine Inc Daily Relative Strength Index (RSI) ChartBG Medicine Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BG Medicine Inc.

BG Medicine Inc Daily Stochastic Oscillator ChartBG Medicine Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BG Medicine Inc.

BG Medicine Inc Daily Commodity Channel Index (CCI) ChartBG Medicine Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BG Medicine Inc.

BG Medicine Inc Daily Chande Momentum Oscillator (CMO) ChartBG Medicine Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BG Medicine Inc.

BG Medicine Inc Daily Williams %R ChartBG Medicine Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BG Medicine Inc.

BG Medicine Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BG Medicine Inc.

BG Medicine Inc Daily Average True Range (ATR) ChartBG Medicine Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BG Medicine Inc.

BG Medicine Inc Daily On-Balance Volume (OBV) ChartBG Medicine Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BG Medicine Inc.

BG Medicine Inc Daily Money Flow Index (MFI) ChartBG Medicine Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BG Medicine Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

BG Medicine Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BG Medicine Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of BG Medicine Inc with someone you think should read this too:
  • Are you bullish or bearish on BG Medicine Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BG Medicine Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BG Medicine Inc

I send you an email if I find something interesting about BG Medicine Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BG Medicine Inc.

Receive notifications about BG Medicine Inc in your mailbox!